Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04256213
Title COL Immunotherapy Before Radiochimio + Ipilimumab (COLIBRI)
Acronym COLIBRI
Recruitment Active, not recruiting
Gender female
Phase Phase 0
Variant Requirements No
Sponsors ARCAGY/ GINECO GROUP
Indications
Therapies
Age Groups: adult
Covered Countries FRA


No variant requirements are available.